Erratum: Comparison of bleeding risk and hypofibrinogenemia-associated risk factors between tigecycline with cefoperazone/sulbactam therapy and other tigecycline-based combination therapies
| Main Author: | |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
Frontiers Media S.A.
2024-01-01
|
| Series: | Frontiers in Pharmacology |
| Subjects: | |
| Online Access: | https://www.frontiersin.org/articles/10.3389/fphar.2024.1365927/full |
| _version_ | 1797355234473803776 |
|---|---|
| author | Frontiers Production Office |
| author_facet | Frontiers Production Office |
| author_sort | Frontiers Production Office |
| collection | DOAJ |
| first_indexed | 2024-03-08T14:08:19Z |
| format | Article |
| id | doaj.art-b2b378dfa1e847c187704bc6cab62763 |
| institution | Directory Open Access Journal |
| issn | 1663-9812 |
| language | English |
| last_indexed | 2024-03-08T14:08:19Z |
| publishDate | 2024-01-01 |
| publisher | Frontiers Media S.A. |
| record_format | Article |
| series | Frontiers in Pharmacology |
| spelling | doaj.art-b2b378dfa1e847c187704bc6cab627632024-01-15T04:41:10ZengFrontiers Media S.A.Frontiers in Pharmacology1663-98122024-01-011510.3389/fphar.2024.13659271365927Erratum: Comparison of bleeding risk and hypofibrinogenemia-associated risk factors between tigecycline with cefoperazone/sulbactam therapy and other tigecycline-based combination therapiesFrontiers Production Officehttps://www.frontiersin.org/articles/10.3389/fphar.2024.1365927/fulltigecyclinecefoperazone/sulbactamcarbapenemsβ-lactam antibioticscoagulation disordershypofibrinogenaemia |
| spellingShingle | Frontiers Production Office Erratum: Comparison of bleeding risk and hypofibrinogenemia-associated risk factors between tigecycline with cefoperazone/sulbactam therapy and other tigecycline-based combination therapies Frontiers in Pharmacology tigecycline cefoperazone/sulbactam carbapenems β-lactam antibiotics coagulation disorders hypofibrinogenaemia |
| title | Erratum: Comparison of bleeding risk and hypofibrinogenemia-associated risk factors between tigecycline with cefoperazone/sulbactam therapy and other tigecycline-based combination therapies |
| title_full | Erratum: Comparison of bleeding risk and hypofibrinogenemia-associated risk factors between tigecycline with cefoperazone/sulbactam therapy and other tigecycline-based combination therapies |
| title_fullStr | Erratum: Comparison of bleeding risk and hypofibrinogenemia-associated risk factors between tigecycline with cefoperazone/sulbactam therapy and other tigecycline-based combination therapies |
| title_full_unstemmed | Erratum: Comparison of bleeding risk and hypofibrinogenemia-associated risk factors between tigecycline with cefoperazone/sulbactam therapy and other tigecycline-based combination therapies |
| title_short | Erratum: Comparison of bleeding risk and hypofibrinogenemia-associated risk factors between tigecycline with cefoperazone/sulbactam therapy and other tigecycline-based combination therapies |
| title_sort | erratum comparison of bleeding risk and hypofibrinogenemia associated risk factors between tigecycline with cefoperazone sulbactam therapy and other tigecycline based combination therapies |
| topic | tigecycline cefoperazone/sulbactam carbapenems β-lactam antibiotics coagulation disorders hypofibrinogenaemia |
| url | https://www.frontiersin.org/articles/10.3389/fphar.2024.1365927/full |
| work_keys_str_mv | AT frontiersproductionoffice erratumcomparisonofbleedingriskandhypofibrinogenemiaassociatedriskfactorsbetweentigecyclinewithcefoperazonesulbactamtherapyandothertigecyclinebasedcombinationtherapies |